Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-11
2010-10-19
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S106000, C544S358000, C546S290000, C546S304000, C548S316400, C548S326500, C548S541000, C548S557000, C549S475000, C549S480000, C514S231200, C514S255010, C514S255020, C514S344000, C514S352000, C514S424000, C514S426000, C514S471000, C514S473000, C514S511000, C560S147000
Reexamination Certificate
active
07816389
ABSTRACT:
14-O—[(((C1-6)Alkoxy-(C1-6)alkyl)-phenylsulfanyl)-acetyl]-mutilins, 14-O—[(((C1-6)Mono- or dialkylamino-(C1-6)alkyl)-phenylsulfanyl)-acetyl]-mutilins, 14-O-[((Hydroxy-(C1-6)-alkyl)-phenylsulfanyl)-acetyl]-mutilins, 14-O-[((Formyl-(C0-5)-alkyl)-phenylsulfanyl)-acetyl]-mutilins, 14-O-[((Guanidino-imino-(C1-6)alkyl)-phenylsulfanyl)-acetyl]-mutilins, 14-O-[((Ureido-imino-(C1-6)alkyl)-phenylsulfanyl)-acetyl]-mutilins, 14-O-[((Thioureido-imino-(C1-6)alkyl)-phenylsulfanyl)-acetyl]-mutilins, 14-O-[((Isothioureido-imino-(C1-6)alkyl)-phenylsulfanyl)-acetyl]-mutilins and their use as pharmaceuticals.
REFERENCES:
patent: 6753445 (2004-06-01), Ascher et al.
patent: 7169804 (2007-01-01), Ascher et al.
patent: 7569587 (2009-08-01), Ascher et al.
patent: 2005/0131023 (2005-06-01), Ascher et al.
patent: 2005/0215637 (2005-09-01), Ascher et al.
patent: 2005/0250811 (2005-11-01), Berner et al.
patent: 2007/0270404 (2007-11-01), Ascher et al.
patent: 2008/0287442 (2008-11-01), Thirring et al.
patent: 2008/0306072 (2008-12-01), Mang et al.
patent: 2009/0118366 (2009-05-01), Mang et al.
patent: 0 013 768 (1980-08-01), None
patent: 1 231 915 (2005-02-01), None
patent: WO 01/09095 (2001-02-01), None
patent: WO 2004/089886 (2004-10-01), None
patent: WO 2007/000001 (2007-01-01), None
patent: WO 2007/000004 (2007-01-01), None
Krishna, P.S. Murali et al., “Production of rifamycin SV using mutant strains ofAmycolatopsis mediterraneiMTCC17,” World Journal of Microbiology & Biotechnology, 1999. vol. 15, pp. 741-743.
Riedl, K. 1976. Studies on pleuromutilin and some of its derivatives.The Journal of Antibiotics, 29(2):132-139.
International Search Report from PCT/AT2007/000009 dated Apr. 13, 2007.
Written Opinion of the International Searching Authority from PCT/AT2007/000009 dated Apr. 13, 2007.
Ascher Gerd
Heilmayer Werner
Novak Rodger
Paukner Susanne
Thirring Klaus
Coppins Janet L
Knobbe Martens Olson & Bear LLP
Nabriva Therapeutics Forschungs GmbH
Saeed Kamal A
LandOfFree
Organic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Organic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Organic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4151424